Artikel dengan mandat akses publik - lawrence steinmanPelajari lebih lanjut
KeseluruhanNIHDFGCIHRHHMIGovernment of ItalyJDRFSNSFGovernment of SpainHFSPSwedish Research CouncilCancer Research UKMRCMultiple Sclerosis Society of CanadaNSFDOEDoDNHMRCBanking Foundation "la Caixa"TelethonParkinson's UKEuropean CommissionDoris Duke Charitable FoundationANRPCORILeducq Foundation, USA
Tidak tersedia di mana pun: 12
Prolactin: a versatile regulator of inflammation and autoimmune pathology
M Costanza, N Binart, L Steinman, R Pedotti
Autoimmunity reviews 14 (3), 223-230, 2015
Mandat: Government of Italy
New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis
P Villoslada, L Steinman
Expert opinion on investigational drugs 29 (5), 443-459, 2020
Mandat: US National Institutes of Health, Government of Spain
Iron‐sulfur glutaredoxin 2 protects oligodendrocytes against damage induced by nitric oxide release from activated microglia
K Lepka, K Volbracht, E Bill, R Schneider, N Rios, T Hildebrandt, ...
Glia 65 (9), 1521-1534, 2017
Mandat: German Research Foundation, Swedish Research Council
Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration
ME van Strien, HE de Vries, NL Chrobok, JGJM Bol, JJP Breve, ...
Brain, behavior, and immunity 50, 141-154, 2015
Mandat: European Commission
Thymic epithelium determines a spontaneous chronic neuritis in Icam1tm1JcgrNOD Mice
G Meyer zu Horste, AK Mausberg, S Cordes, H El-Haddad, HJ Partke, ...
The Journal of Immunology 193 (6), 2678-2690, 2014
Mandat: German Research Foundation
CRYAB modulates the activation of CD4+ T cells from relapsing–remitting multiple sclerosis patients
QL Quach, LM Metz, JC Thomas, JB Rothbard, L Steinman, SS Ousman
Multiple Sclerosis Journal 19 (14), 1867-1877, 2013
Mandat: Canadian Institutes of Health Research, Multiple Sclerosis Society of Canada
Induction of new autoimmune diseases after alemtuzumab therapy for multiple sclerosis: learning from adversity
L Steinman
JAMA neurology 74 (8), 907-908, 2017
Mandat: US National Institutes of Health
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal
L Steinman
Immunologic Research 58, 307-314, 2014
Mandat: US National Institutes of Health
Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis
M Costanza, M Di Dario, L Steinman, C Farina, R Pedotti
Journal of Neuroimmunology 277 (1-2), 186-188, 2014
Mandat: Government of Italy
Myeloid cell replacement is neuroprotective in chronic experimental autoimmune encephalomyelitis
MMD Mader, A Napole, D Wu, M Atkins, A Scavetti, Y Shibuya, A Foltz, ...
Nature neuroscience 27 (5), 901-912, 2024
Mandat: Howard Hughes Medical Institute
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future
L Steinman
Revue neurologique 170 (10), 602-607, 2014
Mandat: US National Institutes of Health
Therapy of Autoimmune Diseases Using Antibodies to Molecules of the Major Histocompatibility Complex
L Steinman, SS Zamvil, J Trotter, S Sriram, MK Waldor
Perspectives on Autoimmunity, 201-209, 2020
Mandat: US National Institutes of Health
Tersedia di suatu tempat: 140
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain
X Zhuang, X Xiang, W Grizzle, D Sun, S Zhang, RC Axtell, S Ju, J Mu, ...
Molecular Therapy 19 (10), 1769-1779, 2011
Mandat: US National Institutes of Health
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
TV Lanz, RC Brewer, PP Ho, JS Moon, KM Jude, D Fernandez, ...
Nature 603 (7900), 321-327, 2022
Mandat: US Department of Energy, US National Institutes of Health, Howard Hughes …
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
RC Axtell, BA De Jong, K Boniface, LF Van Der Voort, R Bhat, P De Sarno, ...
Nature medicine 16 (4), 406-412, 2010
Mandat: US National Institutes of Health
1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
S Joshi, LC Pantalena, XK Liu, SL Gaffen, H Liu, C Rohowsky-Kochan, ...
Molecular and cellular biology 31 (17), 3653-3669, 2011
Mandat: US National Institutes of Health
Inhibitory role for GABA in autoimmune inflammation
R Bhat, R Axtell, A Mitra, M Miranda, C Lock, RW Tsien, L Steinman
Proceedings of the National Academy of Sciences 107 (6), 2580-2585, 2010
Mandat: US National Institutes of Health
Thymic selection determines γδ T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon γ
KDC Jensen, X Su, S Shin, L Li, S Youssef, S Yamasaki, L Steinman, ...
Immunity 29 (1), 90-100, 2008
Mandat: US National Institutes of Health
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
MS Weber, T Prod'homme, S Youssef, SE Dunn, CD Rundle, L Lee, ...
Nature medicine 13 (8), 935-943, 2007
Mandat: German Research Foundation
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
A Marabelle, H Kohrt, I Sagiv-Barfi, B Ajami, RC Axtell, G Zhou, ...
The Journal of clinical investigation 123 (6), 2447-2463, 2013
Mandat: US National Institutes of Health
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer